Celltrion | 068270 - PE价格收益

金融业

KRW

KRW 768.81B

现金及等价物

KRW 56.79B

KRW 92.83B

KRW 481.57B

KRW 292.71B

KRW 160.58B

股息收益率

0.38

KRW 13.41B

KRW 19.64B

1.07K

EPS每股收益

KRW 1.35K

股本和储备

KRW 434.82B

KRW 39.29B

债务利息支出

KRW 19B

KRW 779.01M

KRW 411.27B

KRW 38061.93B

KRW 8.82B

KRW 119.22B

KRW 12.9B

普通股股本

KRW 229.65M

58.97

KRW 11.84B

KRW 1240B

销售和管理费用

KRW 9.32B

KRW 126B

贸易债权人

KRW 88.58B

应收帐款人

KRW 2009.82B

	Pe	更改		日
Akebia Therapeutics	1.63K		1.6K	2025-12
Celltrion	58.97		8.86	2026-03
Dianthus Therapeutics	3.8		1.53	2024-09
Ionis Pharmaceuticals	396.15		79.28	2022-09
IQVIA Holdings	19.37		7.21	2026-03
Moderna	27.22		14.51	2023-06
Organon & Co	8.32		4.57	2026-03
Revvity	30.79		19.08	2026-03
Tectonic Therapeutic	4.01		0.63	2024-03
Viatris	14.61		4.21	2026-03
Xeris Pharmaceuticals	76.05		2.37K	2026-03